
Please try another search
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of drugs and medical devices derived from plants. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, ABV-1703 and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1702 is used to treat myelodysplastic syndrome (MDS). ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. Its ABV-1519 is used for the treatment of non-small cell lung cancer.
Name | Age | Since | Title |
---|---|---|---|
Eugene Jiang | 37 | 2015 | Chairman & Chief Business Officer |
Norimi Sakamoto | 53 | 2017 | Independent Director |
Yen-Hsin Chou | 35 | 2017 | Independent Director |
Susanna Cunningham-Rundles | - | - | Member of Scientific Advisory Board |
Yoshinobu Odaira | 74 | 2019 | Independent Director |
Tsang Ming Jiang | 63 | 2017 | Director |
Chang-Jen Jiang | 67 | 2017 | Director |
Keith McBurnett | - | 2023 | Member of Scientific Advisory Board |
Thomas P. Laughren | - | 2023 | Member of Scientific Advisory Board |
Yu-Min Chung | 58 | 2022 | Independent Director |
Shuling Jiang | 67 | 2022 | Director |
Hsin-Hui Miao | 55 | 2022 | Independent Director |
Yih-Shiou Hwang | - | 2023 | Member of Scientific Advisory Board |
Maurizio Fava | - | 2023 | Member of Scientific Advisory Board |
Che-Wei Hsu | 42 | 2022 | Independent Director |
Tsung-Shann Jiang | 69 | 2019 | Chief Scientific Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review